导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 35.92% | 84/4773 |
| 近一周 | 2.44% | 97/5465 |
| 近一月 | -6.02% | 4007/5421 |
| 近一季 | -9.74% | 3626/5231 |
| 近半年 | 26.71% | 100/4920 |
| 近一年 | 42.80% | 108/4394 |
| 近两年 | 200.53% | 86/2954 |
| 近三年 | 131.22% | 57/2253 |
| 成立以来 | 195.93% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.22% 3080/4961 |
103.66% 81/5312 |
- - |
- - |
| 2025 | 41.95% 716/4813 |
3.81% 1035/3635 |
-0.05% 2793/4076 |
46.68% 526/4524 |
-6.73% 3729/4813 |
| 2024 | 23.49% 334/3463 |
-11.42% 2431/2808 |
0.46% 604/3014 |
16.91% 1318/3129 |
18.71% 66/3463 |
| 2023 | -2.03% 552/2656 |
17.39% 174/2280 |
-7.91% 1930/2385 |
-8.85% 1738/2515 |
-0.58% 230/2655 |
| 2022 | -34.05% 1711/2207 |
-19.98% 1514/1919 |
-0.41% 1621/2016 |
-17.61% 1624/2113 |
0.44% 1492/2208 |
| 2021 | 22.27% 150/1822 |
-13.50% 1157/1255 |
45.38% 9/1330 |
-6.03% 894/1466 |
3.48% 427/1822 |
| 2020 | 42.15% 274/1250 |
9.24% 28/1028 |
27.56% 129/1067 |
-3.48% 1091/1164 |
5.69% 777/1184 |
| 2019 | - - |
- - |
- - |
21.41% 4/850 |
17.98% 10/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国联安中证半导体ETF联接C VS. 长安沪深300非周期A(740101) |